SIGYN THERAPEUTICS, INC. Net Income (Loss) Available to Common Stockholders, Basic
SIGYN THERAPEUTICS, INC. (SIGY) reported Net Income (Loss) Available to Common Stockholders, Basic of -$138.57 thousand for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2019-11-12
- SIGYN THERAPEUTICS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2019-09-30 was -$138.57K.
- SIGYN THERAPEUTICS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2019-06-30 was -$116.82K.
- SIGYN THERAPEUTICS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2019-03-31 was $53.96K.
- SIGYN THERAPEUTICS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2018-09-30 was -$355.99K.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month |
|---|---|---|---|
| 2019-09-30 | -$138.57K 10-Q · filed 2019-11-12 | -$255.39K derived: sum of 2 quarters · filed 2019-11-12 | -$201.43K 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$116.82K 10-Q · filed 2019-08-05 | -$62.86K 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $53.96K 10-Q · filed 2019-04-19 | ||
| 2018-09-30 | -$355.99K 10-Q · filed 2019-11-12 | -$663.26K derived: sum of 2 quarters · filed 2019-11-12 | -$1.40M 10-Q · filed 2019-11-12 |
| 2018-06-30 | -$307.28K 10-Q · filed 2019-08-05 | -$1.05M 10-Q · filed 2019-08-05 | |
| 2018-03-31 | -$739.39K 10-Q · filed 2019-04-19 |